Autolus Therapeutics PLC (AUTL)
3.01
-0.28
(-8.51%)
USD |
NASDAQ |
Nov 14, 16:00
3.22
+0.21
(+6.98%)
Pre-Market: 08:54
Autolus Therapeutics Cash and Short Term Investments (Quarterly): 705.94M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 705.94M |
| March 31, 2024 | 758.53M |
| December 31, 2023 | 239.57M |
| September 30, 2023 | 256.42M |
| June 30, 2023 | 307.50M |
| March 31, 2023 | 343.03M |
| December 31, 2022 | 382.44M |
| September 30, 2022 | 163.05M |
| June 30, 2022 | 216.44M |
| March 31, 2022 | 268.56M |
| December 31, 2021 | 310.34M |
| September 30, 2021 | 173.06M |
| Date | Value |
|---|---|
| June 30, 2021 | 216.35M |
| March 31, 2021 | 239.01M |
| December 31, 2020 | 153.30M |
| September 30, 2020 | 177.70M |
| June 30, 2020 | 212.04M |
| March 31, 2020 | 243.31M |
| December 31, 2019 | 210.64M |
| September 30, 2019 | 229.37M |
| June 30, 2019 | 266.19M |
| March 31, 2019 | 187.73M |
| March 31, 2018 | 120.67M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
153.30M
Minimum
Dec 2020
758.53M
Maximum
Mar 2024
293.54M
Average
239.57M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 214.79M |
| Biodexa Pharmaceuticals PLC | 6.394M |
| NuCana PLC | 14.72M |
| TC BioPharm (Holdings) PLC | 1.238M |
| Verona Pharma PLC | 336.04M |